Bridgewater Associates’s BioMarin Pharmaceuticals BMRN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$11.7M	Sell	206,911 -23,050	-10%	-$1.34M	0.05%	243
2025 Q4	$13.7M	Sell	229,961 -145,722	-39%	-$7.93M	0.05%	276
2025 Q3	$20.3M	Buy	375,683 +147,937	+65%	+$8.46M	0.08%	196
2025 Q2	$12.5M	Buy	227,746 +104,090	+84%	+$6.13M	0.05%	231
2025 Q1	$8.74M	Sell	123,656 -178,824	-59%	-$12M	0.04%	281
2024 Q4	$19.9M	Buy	302,480 +160,166	+113%	+$10.7M	0.09%	168
2024 Q3	$10M	Buy	142,314 +107,330	+307%	+$8.97M	0.06%	262
2024 Q2	$2.88M	Buy	34,984 +31,618	+939%	+$2.63M	0.02%	465
2024 Q1	$294K	Sell	3,366 -187,604	-98%	-$16.8M	﹤0.01%	657
2023 Q4	$18.4M	Buy	190,970 +29,576	+18%	+$2.62M	0.1%	152
2023 Q3	$14.3M	Buy	161,394 +11,418	+8%	+$1.02M	0.09%	177
2023 Q2	$13M	Buy	149,976 +25,932	+21%	+$2.44M	0.08%	170
2023 Q1	$12.1M	Buy	124,044 +17,665	+17%	+$1.83M	0.07%	184
2022 Q4	$11M	Sell	106,379 -1,165	-1%	-$109K	0.06%	239
2022 Q3	$9.12M	Buy	107,544 +67,829	+171%	+$6.04M	0.05%	266
2022 Q2	$3.29M	Buy	39,715 +20,065	+102%	+$1.6M	0.01%	592
2022 Q1	$1.51M	Buy	19,650 +5,667	+41%	+$474K	0.01%	736
2021 Q4	$1.24M	Sell	13,983 -27	-0.2%	-$2.23K	0.01%	536
2021 Q3	$1.08M	Sell	14,010 -9,171	-40%	-$724K	0.01%	503
2021 Q2	$1.93M	Buy	23,181 +9,743	+73%	+$772K	0.01%	494
2021 Q1	$1.01M	Buy	+13,438	New	+$1.1M	0.01%	313
2016 Q4	–	Sell	-8,926	Closed	-$826K	–	284
2016 Q3	$826K	Buy	+8,926	New	+$841K	0.01%	234
2014 Q2	–	Sell	-48,400	Closed	-$3.3M	–	319
2014 Q1	$3.3M	Buy	+48,400	New	+$3.57M	0.03%	148